Whatever the outcome of the first New Jersey Vioxx trial, lawyers on both sides are less likely to be surprised than they were over the $253 million verdict in Texas against Merck & Co. That's because Judge Carol Higbee is letting jurors question witnesses. For the lawyers in the case, juror questions are sources of early feedback. And since the trial is being covered live by Court TV Extra, it's becoming an educational laboratory for lawyers on both sides of mass tort cases nationwide.
Font Size: 
Keen Questioning by Jurors Demystifies Vioxx Trial
New Jersey Law Journal
October 5, 2005
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.
